Innovative practices that change the world

Innovative practices that change the world
Innovative practices that change the world

Sponsored content

According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death worldwide. They cause around 17.9 million deaths each year, far ahead of cancer, which we fear more. A worrying situation, but one that cutting-edge medical research has made it possible to improve thanks to spectacular advances in prevention and treatment over the past fifty years. The Montreal Heart Institute, whose reputation for excellence extends beyond our borders, is a key player in the fight against cardiovascular diseases on a global scale. For 70 years now, the ICM has carried the audacity and visionary spirit of its founder with the ambition of reducing mortality linked to cardiovascular diseases by 30% within 10 years. The hope, that of saving even more lives, is palpable.

From pioneer to leader

The sense of innovation is inscribed in the DNA of the Montreal Heart Institute (ICM). Founded in 1954 by Dr. Paul David, the Institute has had a series of audacious projects and unprecedented achievements since its beginnings. Already in 1968, Dr. Pierre Grondin performed the first successful heart transplant in Canada under the direction of Dr. David. Shortly after, the Institute was the first Canadian health establishment recognized by the WHO for its prevention actions.

Today, the Montreal Heart Institute is a world leader in cardiovascular medicine, thanks in particular to what has become the most important cardiology research center in Quebec and Canada. The center stands out for its connection between clinical and fundamental research, which creates a perfect and innovative synergy for the study of cardiovascular diseases and medical practice.

Since 2008, a new entity has been added to the armada of the fight against cardiovascular diseases of the Montreal Heart Institute. The Beaulieu-Saucier Pharmacogenomic Center at the ICM is dedicated to the advancement of knowledge and the field of precision medicine using pharmacogenomic research, a path for the future. For its director, Dr. Marie-Pierre Dubé, it is nothing less than a revolution in the treatment and prevention of cardiovascular diseases that is at work. “The potential of what we call precision medicine is incredible. Already used successfully in oncology, it makes it possible to understand not only the impact of genetic factors in the development of cardiovascular diseases, but also to predict the effects of drug treatments administered to patients using data collected and analyzed continuously. We will therefore be able to prescribe the right medication to the right person at the right time with greater acuity and we will be able to better identify individuals at risk of cardiovascular disease before symptoms appear,” she explains.

An undeniable impact

Alain Gignac, president of the Montreal Heart Institute Foundation, speaks with pride of 70 years of progress, both in terms of understanding cardiovascular diseases and their treatment and prevention. As proof, patients suffering from cardiovascular disease today exceed the average age of life expectancy — in Quebec — and the duration of hospitalizations following an intervention has been reduced by 75%. But the Institute owes these impressive results to an entire community of courageous patients, daring experts, allies and generous contributors, including some of the greatest philanthropists the country has known. Let us name in particular Jean-Louis Lévesque, a Montreal financier, who contributed 10 million until his death in 1995.

After 400 million raised and invested in the fight against cardiovascular diseases since 1977, Mr. Gignac insists on the importance of the concerted goodwill of all the actors who are involved directly or indirectly in care, prevention and awareness . “Saving a life is not a singular thing. Behind each heart that beats before, during and after illness, an entire ecosystem is orchestrated. At the slightest change in rhythm, whether a heart beats too fast, too loudly or becomes too quiet, it is by perfectly attuning to each other that the nursing staff at the Montreal Heart Institute provide the tempo. »

An indispensable ally: the Montreal Heart Institute Foundation

Created in 1977, the Montreal Heart Institute Foundation collects and administers funds to support the implementation of the Institute’s innovative and priority projects in the fight against cardiovascular diseases. Its philanthropic events and the contributions of its donors have allowed it to become the most important cardiology research center in the country. Since its creation, the Montreal Heart Institute Foundation has received the support of 25,957 donors, without whom the important discoveries that have changed the lives of people suffering from cardiovascular disease would have been impossible. Thanks to them as well as the specialists, professionals and researchers at the Institute, tens of thousands of patients in Quebec have been able to receive the best care possible.

I support the Montreal Heart Institute

This content was produced by the Special Publications team at Duty, relating to marketing. The writing of the Duty did not take part.

To learn more about the Montreal Heart Institute Foundation



PREV These drug-resistant bacteria pose the biggest threat to human health
NEXT To live a healthy and old age, ride a bike